KR910019610A - 고수화된 자체유지 필름 형태의 겔, 이의 제조방법 및 피부병변 및/혹은 병리치료에서의 이의 용도 - Google Patents
고수화된 자체유지 필름 형태의 겔, 이의 제조방법 및 피부병변 및/혹은 병리치료에서의 이의 용도 Download PDFInfo
- Publication number
- KR910019610A KR910019610A KR1019910008914A KR910008914A KR910019610A KR 910019610 A KR910019610 A KR 910019610A KR 1019910008914 A KR1019910008914 A KR 1019910008914A KR 910008914 A KR910008914 A KR 910008914A KR 910019610 A KR910019610 A KR 910019610A
- Authority
- KR
- South Korea
- Prior art keywords
- gel
- alkali metal
- alginic acid
- highly hydrated
- polyhydric alcohol
- Prior art date
Links
- 230000007170 pathology Effects 0.000 title claims 2
- 231100000444 skin lesion Toxicity 0.000 title claims 2
- 206010040882 skin lesion Diseases 0.000 title claims 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 238000000034 method Methods 0.000 claims 11
- 235000010443 alginic acid Nutrition 0.000 claims 7
- 239000000783 alginic acid Substances 0.000 claims 7
- 229960001126 alginic acid Drugs 0.000 claims 7
- 229920000615 alginic acid Polymers 0.000 claims 7
- 229910052783 alkali metal Inorganic materials 0.000 claims 7
- -1 alkaline earth metal alginic acid Chemical class 0.000 claims 7
- 150000005846 sugar alcohols Polymers 0.000 claims 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 6
- 229920001477 hydrophilic polymer Polymers 0.000 claims 4
- 229920000642 polymer Polymers 0.000 claims 3
- 229920002385 Sodium hyaluronate Polymers 0.000 claims 2
- 239000011575 calcium Substances 0.000 claims 2
- 230000015271 coagulation Effects 0.000 claims 2
- 238000005345 coagulation Methods 0.000 claims 2
- 239000012530 fluid Substances 0.000 claims 2
- 150000002500 ions Chemical class 0.000 claims 2
- 229940010747 sodium hyaluronate Drugs 0.000 claims 2
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical group [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 1
- 150000001340 alkali metals Chemical class 0.000 claims 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims 1
- 239000000648 calcium alginate Substances 0.000 claims 1
- 235000010410 calcium alginate Nutrition 0.000 claims 1
- 229960002681 calcium alginate Drugs 0.000 claims 1
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- CEVCTNCUIVEQOY-STXHBLNNSA-N fumagillol Chemical compound C([C@@H](O)[C@H](C1[C@]2(C)[C@H](O2)CC=C(C)C)OC)C[C@@]21CO2 CEVCTNCUIVEQOY-STXHBLNNSA-N 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- 239000000661 sodium alginate Substances 0.000 claims 1
- 235000010413 sodium alginate Nutrition 0.000 claims 1
- 229940005550 sodium alginate Drugs 0.000 claims 1
- 239000000499 gel Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/225—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/28—Polysaccharides or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/04—Alginic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/13—Burn treatment
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도는 본 발명에 따른 고수화된 자체유지 필름형태의 겔의 제조방법을 도시하는 도시도.
Claims (22)
- 하나이상의 알칼리 금속 알간사 1%내지 7.5%, 알칼리 토금속 알긴산 0.1%내지 5%, 다가알코올 0.1내지 10%및 친구성의 천연, 합성 또는 반합성 중합체 0.05%내지 10%의 양을 포함하는 것을 특징으로하는 고수화된 자체 유지 필름형태의 겔.
- 제1항에 있어서, 하나 이상의 알칼리금속 알긴산 3.5%를 포함하는 것을 특징으로 하는 고수화된 자체 유지 필름 형태의 겔.
- 제2항에 있어서, 상기 알칼리 금속 알긴산이 나트륨임을 특징으로하는 고수화된 자체 유지 필름 형태의 겔.
- 제1항에 있어서, 알긴산 칼슘 1%를 포함하는 것을 특징으로하는 고수화된 자체 유지 필름 형태의 겔.
- 제1항에 있어서, 다가알코올 5%를 포함하는 것을 특징으로하는 고수화된 자체 유지 필름 형태의 겔.
- 제5항에 있어서, 상기 다가알코올은 글리세롤임을 특징으로하는 고수화된 자체 유지 필름 형태의 겔.
- 제1항에 있어서, 친수성 중합체 0.5%를 포함하는 것을 특징으로 하는 고수화된 자체 유지 필름 형태의 겔.
- 제7항에 있어서, 상기 친수성 중합체는 히알루론산 나트륨 인것을 특징으로하는 고수화된 자체 유지 필름 형태의 겔.
- 제1항에 있어서, 약제가 상기 필름을 포함하는 것을 특징으로하는 고수화된 자체 유지 필름 형태의 겔.
- 하나이상의 알칼리금속 알긴산을 함유하는 최초 유체 겔 및 다가알코올을 변화 가능한 폭 및 두께의 슬릿을 통하여 핑핑하여 압출하고, 온도가 15℃내지 40℃이고 Ca2+이온농도가 0.1%내지 10%인 연속 응고욕 2내지 4개를 통과시킴으로서 응고되는 것을 특징으로하는 고수화된 자체 유지 필름 형태의 겔을 제조하는 방법.
- 제10항에 있어서. 상기 최초 유체겔이 친수성의 천연, 합성 반합성 중합체를 또한 포함하는 것을 특징으로 하는 방법.
- 제11항에 있어서, 상기 최초 겔이 하나이상의 알칼리금속 알긴산 3.5%내지 7.5% 다가알코온 0.5%내지 7.5%, 친수성의 천연 합성 또는 반합성 중합체 0.1%내지 10%를 포함하는 것을 특징으로 하는 방법.
- 제12항에 있어서, 상기 알칼리 금속 알긴산 함량이 3.5%임을 특징으로 하는 방법.
- 제13항에 있어서, 상기 알칼리금속 알긴산이 알긴산나트륨임을 특징으로 하는 방법.
- 제12항에 있어서, 상기 다가알코올 함량이 5%임을 특징으로 하는 방법.
- 제15항에 있어서, 상기 다가 알코올이 글리세롤임을 특징으로 하는 방법.
- 제12항에 있어서, 상기 친수성 중합체 함량이 0.2%임을 특징으로 하는 방법.
- 제17항에 있어서, 상기 친수성 중합체 히알루론산 나트륨인 것을 특징으로 하는 방법.
- 제12항에 있어서, 제1욕에서 상기 Ca2+이온 농도가 1%이며 그 다음 욕에서 2%임을 특징으로 하는 방법.
- 제12항에 있어서, 제1욕에서 상기 20°이며 그 다음욕에서 30°임을 특징으로 하는 방법.
- 제12항에 있어서, 2개의 응고욕이 제공되는 것을 특징으로 하는 방법.
- 피부병변 및/혹은 병리를 치료하기 위한 특허청구범위 제1항에서 청구한 고수화된 자체 유지 필름 형태의 겔의 용도※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT02047790A IT1248666B (it) | 1990-05-30 | 1990-05-30 | Gel in forma di film autosupportanti altamente idrati, processo per laloro preparazione e impiego nella terapia di lesioni e/o patologie cutanee |
| IT20477 | 1990-05-30 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR910019610A true KR910019610A (ko) | 1991-12-19 |
| KR0184884B1 KR0184884B1 (ko) | 1999-05-01 |
Family
ID=11167535
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019910008914A KR0184884B1 (ko) | 1990-05-30 | 1991-05-30 | 고수화된 자체지지 필름형태의 겔, 이의 제조방법 및 이를 포함하는 약제학적 조성물 |
Country Status (22)
| Country | Link |
|---|---|
| US (3) | US5523093A (ko) |
| EP (1) | EP0459378B1 (ko) |
| JP (1) | JP2960204B2 (ko) |
| KR (1) | KR0184884B1 (ko) |
| AT (1) | ATE141520T1 (ko) |
| AU (1) | AU7806791A (ko) |
| BR (1) | BR9102226A (ko) |
| CA (1) | CA2043450C (ko) |
| DE (1) | DE69121471T2 (ko) |
| DK (1) | DK0459378T3 (ko) |
| ES (1) | ES2093654T3 (ko) |
| FI (1) | FI104148B1 (ko) |
| GR (1) | GR3021259T3 (ko) |
| HU (1) | HU208069B (ko) |
| IE (1) | IE75717B1 (ko) |
| IL (1) | IL98254A (ko) |
| IN (1) | IN172300B (ko) |
| IT (1) | IT1248666B (ko) |
| NO (1) | NO304402B1 (ko) |
| PT (1) | PT97801B (ko) |
| SG (1) | SG49080A1 (ko) |
| ZA (1) | ZA914041B (ko) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1260154B (it) * | 1992-07-03 | 1996-03-28 | Lanfranco Callegaro | Acido ialuronico e suoi derivati in polimeri interpenetranti (ipn) |
| GB9218749D0 (en) * | 1992-09-04 | 1992-10-21 | Courtaulds Plc | Alginate gels |
| GB2275686B (en) * | 1993-03-03 | 1997-04-30 | Johnson & Johnson Medical | Swellable wound dressing materials |
| GB2275685B (en) * | 1993-03-03 | 1997-04-30 | Johnson & Johnson Medical | Water soluble wound dressing materials |
| GB9414303D0 (en) * | 1994-07-15 | 1994-09-07 | C V Lab Ltd | Alginate fibres, method of preparation and use |
| GB2291348B (en) * | 1994-07-18 | 1999-01-20 | Johnson & Johnson Medical | Sterile gel composition for wound treatment comprising alginate and polyhydric alcohol |
| WO1996013285A1 (en) * | 1994-10-28 | 1996-05-09 | Innovative Technologies Limited | Dehydrated hydrogels |
| US5621093A (en) * | 1995-06-06 | 1997-04-15 | Anika Research, Inc. | Steam-sterilizing solid hyaluronic acid |
| GB9514361D0 (en) * | 1995-07-13 | 1995-09-13 | Bristol Myers Squibb Co | A film for topical use in the treatment of wounds |
| AU6525296A (en) * | 1995-07-19 | 1997-02-18 | Innovative Technologies Limited | Wound treatment composition |
| GB9522314D0 (en) * | 1995-11-01 | 1996-01-03 | Bristol Myers Squibb Co | Water soluble films |
| GB9608222D0 (en) * | 1996-04-20 | 1996-06-26 | Innovative Tech Ltd | Dehydrated hydrogels |
| US6060534A (en) | 1996-07-11 | 2000-05-09 | Scimed Life Systems, Inc. | Medical devices comprising ionically and non-ionically crosslinked polymer hydrogels having improved mechanical properties |
| US6281341B1 (en) * | 1997-04-30 | 2001-08-28 | Biomm, Inc. & University Of Miami | Hetero-polysaccharide conjugate and methods of making and using the same |
| US5976150A (en) * | 1998-08-25 | 1999-11-02 | Alcon Laboratories, Inc. | Intraocular lens injection system |
| US6890912B2 (en) | 2000-07-21 | 2005-05-10 | Mark B. Lyles | Sunscreen formulations containing nucleic acids |
| JP3834215B2 (ja) | 2001-09-07 | 2006-10-18 | アグリテクノ矢崎株式会社 | ゲル被覆種子 |
| KR100433363B1 (ko) * | 2002-04-15 | 2004-05-28 | 주식회사 동구제약 | 아시클로버함유 외용필름형성 하이드로겔 제제 |
| CA2484424A1 (en) * | 2003-02-18 | 2004-09-02 | George H. Scherr | Alginate foam compositions |
| HUP0303313A2 (hu) * | 2003-10-09 | 2005-07-28 | Richter Gedeon Vegyészeti Gyár Rt. | Transzdermális gyógyszerkészítmények |
| EP1896649A1 (en) * | 2004-06-24 | 2008-03-12 | Ezio Margiotta | Liquid impermeable material |
| SE530184C2 (sv) * | 2005-12-23 | 2008-03-18 | Kjell Stenberg | Bioadhesiv farmaceutisk filmkomposition innehållande lågviskösa alginater |
| WO2009108760A2 (en) | 2008-02-26 | 2009-09-03 | Board Of Regents, The University Of Texas System | Dendritic macroporous hydrogels prepared by crystal templating |
| JP5435723B2 (ja) * | 2009-01-26 | 2014-03-05 | 公益財団法人北九州産業学術推進機構 | アルギン酸成形体の製造方法 |
| FR2942242B1 (fr) | 2009-02-17 | 2011-06-03 | Laboratoire Tetra Medical | Procede d'obtention d'un element longiforme de polysaccharide, notamment un fil de chitosane et fil de polysaccharide obtenu |
| EP2416741B1 (en) * | 2009-04-06 | 2015-03-11 | Bender Analytical Holding B.V. | In situ gelling alginate systems |
| JP5724356B2 (ja) | 2010-01-19 | 2015-05-27 | 株式会社リコー | 搬送装置、画像形成装置およびプログラム |
| JP2012035233A (ja) * | 2010-08-11 | 2012-02-23 | Seiko Epson Corp | ゲル形成性溶液及びゲル製造方法 |
| US9095558B2 (en) | 2010-10-08 | 2015-08-04 | Board Of Regents, The University Of Texas System | Anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applications |
| WO2012048283A1 (en) | 2010-10-08 | 2012-04-12 | Board Of Regents, The University Of Texas System | One-step processing of hydrogels for mechanically robust and chemically desired features |
| US11565027B2 (en) | 2012-12-11 | 2023-01-31 | Board Of Regents, The University Of Texas System | Hydrogel membrane for adhesion prevention |
| EP3017808B1 (en) * | 2013-07-03 | 2022-07-13 | Ritapharma, Co., Ltd. | Water-soluble hyaluronic acid gel and method for producing same |
| CZ2014451A3 (cs) | 2014-06-30 | 2016-01-13 | Contipro Pharma A.S. | Protinádorová kompozice na bázi kyseliny hyaluronové a anorganických nanočástic, způsob její přípravy a použití |
| CZ309295B6 (cs) * | 2015-03-09 | 2022-08-10 | Contipro A.S. | Samonosný, biodegradabilní film na bázi hydrofobizované kyseliny hyaluronové, způsob jeho přípravy a použití |
| DE102015226167A1 (de) * | 2015-12-21 | 2017-06-22 | Henkel Ag & Co. Kgaa | Haarbehandlungs-Kit mit Hautschutzmittel |
| KR102278232B1 (ko) | 2018-07-04 | 2021-07-15 | 주식회사 엘지화학 | 조성물 및 이를 포함하는 창상 피복재 |
| CN109337130B (zh) * | 2018-09-29 | 2021-03-30 | 青岛大学 | 多糖类聚电解质自支撑薄膜的制备及得到的自支撑薄膜 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB492264A (en) * | 1937-03-13 | 1938-09-13 | Cyril Wilfred Bonniksen | Improvements in or relating to the production of films of alginic material |
| US2512616A (en) * | 1946-01-12 | 1950-06-27 | Johnson & Johnson | Hemostatic alginic surgical dressings |
| GB1329693A (en) * | 1969-09-27 | 1973-09-12 | Wallace Cameron Co Ltd | Haemostatic surgical dressing and a method of manaufacturing same |
| US3640741A (en) * | 1970-02-24 | 1972-02-08 | Hollister Inc | Composition containing gel |
| US4391799A (en) * | 1980-02-15 | 1983-07-05 | The United States Of America As Represented By The Secretary Of The Army | Protective gel composition for treating white phosphorus burn wounds |
| DE3265377D1 (en) * | 1981-05-11 | 1985-09-19 | Tate & Lyle Plc | Immobilized enzymes |
| JPS58206751A (ja) * | 1982-05-26 | 1983-12-02 | 日石三菱株式会社 | 創傷被覆材 |
| US4554166A (en) * | 1984-03-15 | 1985-11-19 | General Foods Corporation | Extrusion process for shrimp or crabmeat analog products in a series of non-boiling gelling baths |
| DE3704907A1 (de) * | 1987-02-17 | 1988-08-25 | Bayer Ag | Topisch anwendbare zubereitungen von gyrase-inhibitoren in kombination mit kortikosteroiden |
| US5071741A (en) * | 1988-04-18 | 1991-12-10 | Cryolife, Inc. | Cryoprotective agent and its use in cryopreservation of cellular matter |
| FR2636339B1 (fr) * | 1988-09-09 | 1992-07-17 | Auge Pier | Gel aqueux a base d'acide hyaluronique et d'acide desoxyribonucleique utilisable en cosmetique, et procede de preparation |
| US4948575A (en) * | 1989-01-24 | 1990-08-14 | Minnesota Mining And Manufacturing Company | Alginate hydrogel foam wound dressing |
-
1990
- 1990-05-30 IT IT02047790A patent/IT1248666B/it active IP Right Grant
-
1991
- 1991-05-24 IL IL98254A patent/IL98254A/xx not_active IP Right Cessation
- 1991-05-28 AT AT91108656T patent/ATE141520T1/de not_active IP Right Cessation
- 1991-05-28 DK DK91108656.9T patent/DK0459378T3/da active
- 1991-05-28 SG SG1996005842A patent/SG49080A1/en unknown
- 1991-05-28 IE IE182491A patent/IE75717B1/en not_active IP Right Cessation
- 1991-05-28 ES ES91108656T patent/ES2093654T3/es not_active Expired - Lifetime
- 1991-05-28 ZA ZA914041A patent/ZA914041B/xx unknown
- 1991-05-28 EP EP91108656A patent/EP0459378B1/en not_active Expired - Lifetime
- 1991-05-28 DE DE69121471T patent/DE69121471T2/de not_active Expired - Lifetime
- 1991-05-29 JP JP3125956A patent/JP2960204B2/ja not_active Expired - Lifetime
- 1991-05-29 NO NO912057A patent/NO304402B1/no not_active IP Right Cessation
- 1991-05-29 FI FI912573A patent/FI104148B1/fi active
- 1991-05-29 BR BR919102226A patent/BR9102226A/pt not_active Application Discontinuation
- 1991-05-29 HU HU911792A patent/HU208069B/hu unknown
- 1991-05-29 PT PT97801A patent/PT97801B/pt not_active IP Right Cessation
- 1991-05-29 CA CA002043450A patent/CA2043450C/en not_active Expired - Lifetime
- 1991-05-30 KR KR1019910008914A patent/KR0184884B1/ko not_active IP Right Cessation
- 1991-05-30 IN IN409CA1991 patent/IN172300B/en unknown
- 1991-05-30 AU AU78067/91A patent/AU7806791A/en not_active Abandoned
- 1991-05-30 US US07/707,790 patent/US5523093A/en not_active Expired - Lifetime
-
1995
- 1995-06-07 US US08/488,049 patent/US5618561A/en not_active Expired - Lifetime
- 1995-06-07 US US08/476,569 patent/US5709877A/en not_active Expired - Lifetime
-
1996
- 1996-10-04 GR GR960402610T patent/GR3021259T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR910019610A (ko) | 고수화된 자체유지 필름 형태의 겔, 이의 제조방법 및 피부병변 및/혹은 병리치료에서의 이의 용도 | |
| DE69022223T2 (de) | Ein abgeändertes gesponnenes fasersystem und verfahren zur herstellung. | |
| ATE114689T1 (de) | Verfahren zur behandlung von kollagen zur erleichterung seiner vernetzung und das so erhaltene kollagen. | |
| ATE157542T1 (de) | Verwendung von einer disaccharidpolysulfat- aluminium verbindung zur herstellung eines medikaments zur behandlung von hämorrhoiden und zur wundheilung | |
| ATE15498T1 (de) | Verfahren zur herstellung von oberflaechenaktiven glykosiden und ihre verwendung in kosmetischen, pharmazeutischen und haushaltsprodukten. | |
| SE8703972D0 (sv) | Ogondroppar | |
| KR870003773A (ko) | 약제학적 조성물 | |
| DE2403269A1 (de) | Mittel zum reinigen von fluessigkeit abgebenden hautoberflaechen, wunden und schleimhaeuten | |
| FI843371A (fi) | Saett foer permanentformning av haoraotervaexten och medel foer genomfoerande av detta. | |
| DE2707164A1 (de) | Chitinloesung und deren verwendung | |
| BR9508888A (pt) | Agente de contraste utilização de um agente de contraste processos para gerar imagens melhoradas de um corpo humano ou de animal não humano e para preparar de um agente de contraste e um polímero polímeros biodegradáveis e implante cirúrgico | |
| US4232003A (en) | Synthetic physiological mucus | |
| TR200002078T2 (tr) | Sentetik polisakkaridler, hazırlanmaları için proses ve bunları içeren farmasötik kompozisyonlar. | |
| US3965908A (en) | Synthetic physiological mucus | |
| DK0789792T3 (da) | Alginattov, fremstillingsmåde og anvendelse | |
| AT354635B (de) | Verfahren zur herstellung klarer , stabiler, waesseriger oder waesserig-alkoholischer loesungen fettloeslicher parfuemoele oder fettloeslicher arzneimittelwirkstoffe | |
| GB1432285A (en) | Polyimide filament and process for its manufacture | |
| FR2498446B1 (fr) | Procede de traitement d'une prothese du type mammaire et prothese obtenue | |
| JPH05331053A (ja) | 腹腔洗浄液 | |
| SE397473B (sv) | Anvendningen av polymerpartiklar som tillsatsmedel i rontgenkontrastmedel baserade pa bariumsulfat eller liknande | |
| ATE189677T1 (de) | Verfahren zur herstellung von furosemide | |
| JP2940930B2 (ja) | 含水アルギン酸フィルムの製造方法 | |
| JPS6462301A (en) | Production of substance having gelling ability | |
| RU2147874C1 (ru) | Состав основы для лекарственных пленок | |
| CN110057647A (zh) | 非离子型kgm固定病理组织样本的新方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| E902 | Notification of reason for refusal | ||
| E701 | Decision to grant or registration of patent right | ||
| GRNT | Written decision to grant | ||
| FPAY | Annual fee payment |
Payment date: 20101116 Year of fee payment: 13 |
|
| EXPY | Expiration of term |